Wytske M van Weerden

30PUBLICATIONS
71CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityImmunogenetics (incl. genetic immunology)Archaeology of New Guinea and Pacific Islands (excl. New Zealand)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Mar 13, 2025
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas.

Konstantinos Vazaios, Patricia Hernández López, Tineke Aarts-Riemens

|Jan 09, 2024
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.

Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen

|Dec 01, 2023
Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma.

Selas T F Bots, Tom J Harryvan, Christianne Groeneveldt

|Nov 09, 2023
Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8<sup>+</sup> T-cell immunity towards cancer cells.

Willemijn van der Wulp, Dennis F G Remst, Michel G D Kester

|Aug 15, 2023
IFNɣ but not IFNα increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity.

Sofia Thomaidou, Amadeo Munoz Garcia, Sabine de Lange

|Mar 08, 2023
Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells.

René van Tienhoven, Maria J L Kracht, Arno R van der Slik

Pageof 5

Frequent Collaborators

9 joint publications

Diana J M van den Wollenberg

5 joint publications

Selas T F Bots

5 joint publications

Nadine van Montfoort

5 joint publications

Christianne Groeneveldt